The RELIANCE I trial results showed that REL-1017-treated patients had a 15.1 point reduction in the MADRS.
The collaboration will remove the need for redundant, manual, and error-prone activities across the clinical lifecycle.
The toolkit is created to integrate with the Suvoda IRT and eConsent, and also address the historical inadequacies that impact eCOA.
Clinical Trials Arena dives into a frequently forgotten aspect of clinical trial diversity: participation of people with cognitive disabilities.
ASC11 was found to have potent antiviral activity against BA.1 and BA.5 Omicron variants.
Get industry leading news, data and analysis delivered to your inbox
The trial evaluated NBI-827104 when given once a day up to 13 weeks in paediatric EE-CSWS patients.
Onternabez plays a key role in mitigating the inflammatory response in various inflammatory condition targets.
After a chaotic 2022 that saw both drug development successes and failures, the Alzheimer’s disease field faces questions over upcoming data and new therapeutic approaches.
The app is integrated with the Medidata Platform, including the Rave EDC, to offer a self-sustaining ecosystem.
The microneedle system, along with an mRNA vaccine candidate, showed enhanced humoral immunity in animal models.
Findings showed that BGE-105 resulted in statistically significant improvements in muscle size, quality, and protein synthesis.
The trial findings showed that LP352 exhibited a strong correlation between plasma and CSF PK concentration.
Grade 1-2, Grade 3, and Grade 4 treatment-related adverse events were reported in the trial.
Assessing overall survival, which is the crucial secondary endpoint of the trial, is progressing.